Eledon Pharmaceuticals, Inc. Purchase Obligation
Eledon Pharmaceuticals, Inc. (ELDN) had Purchase Obligation of $15.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligation · last filed 2026-08-13
- 2026-06-30: Purchase Obligation $15.30M.
- 2026-03-31: Purchase Obligation $4.40M.
- 2025-12-31: Purchase Obligation $9.30M.
- 2025-09-30: Purchase Obligation $7.60M.
| Period end | Purchase Obligation |
|---|---|
| 2026-06-30 | $15.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.40M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $9.30M 10-K · filed 2026-03-19 |
| 2025-09-30 | $7.60M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $6.60M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |